FDA Alerts

venous thromboembolism
venous thromboembolism
FDA Approves New Dose for VTE Drug
11/01/2017
The US Food and Drug Administration recently approved a new dosing option for patients receiving treatment for recurrent venous thromboembolism.
11/01/2017
FDA Alerts
FDA Alerts
FDA Approves New Option for Generalized Myasthenia Gravis
10/25/2017
The US Food and Drug Administration has expanded the approval of a drug to include patients with generalized myasthenia gravis.
10/25/2017
Diabetes Q&A
Diabetes Q&A
FDA Approves Once-Weekly Diabetes Option
10/23/2017
The FDA has approved a new once-weekly, extended-release option for the treatment of adults with type 2 diabetes and uncontrolled blood sugar levels.
10/23/2017
Herpes Zoster
Herpes Zoster
FDA Approves New Herpes Zoster Vaccine
10/23/2017
Based on the results of a clinical trial program, the FDA has approved a new option for the prevention of herpes zoster.
10/23/2017
Drug Therapy
Drug Therapy
FDA: New Indications For Simponi Aria Approved
10/23/2017
After clinical trials demonstrated its safety and efficacy, the US Food and Drug Administration approved Simponi Aria for 2 new indications in adult patients.
10/23/2017
neuropathy
neuropathy
FDA Approves Extended-Release Tablets for Neuropathic Pain
10/12/2017
The US Food and Drug Administration recently approved once-daily extended-release tablets for the management of 2 peripheral neuropathic pain conditions.
10/12/2017
Knee pain
Knee pain
FDA Approves Extended-Release Intra-Articular Injection
10/10/2017
After results from a clinical trial demonstrated its safety and efficacy, the US Food and Drug Administration recently approved the first and only extended-release intra-articular injection for patients...
10/10/2017
Multiple Sclerosis
Multiple Sclerosis
FDA Approves Generic Option for Relapsing Forms of MS
10/04/2017
The FDA has approved a generic option for the treatment of patients with relapsing forms of multiple sclerosis. For details, including dosage and common adverse effects, read more.
10/04/2017
Diabetes Q&A
Diabetes Q&A
FDA Approves New Fast-Acting Insulin
09/29/2017
The FDA has approved a new option for glycemic control in adults with type 1 and type 2 diabetes. For details, including dosing and adverse events, read more.
09/29/2017
Diabetes Q&A
Diabetes Q&A
Newly Approved Continuous Glucose Monitoring System Does Not Require Fingerstick
09/28/2017
The US Food and Drug Administration has approved a new continuous glucose monitoring system for adult patients with diabetes.
09/28/2017